Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PSCA Antikörper

PSCA Reaktivität: Human, Maus WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7254328
  • Target Alle PSCA Antikörper anzeigen
    PSCA (Prostate Stem Cell Antigen (PSCA))
    Reaktivität
    • 60
    • 20
    • 10
    • 2
    • 2
    • 2
    Human, Maus
    Wirt
    • 51
    • 9
    • 1
    Kaninchen
    Klonalität
    • 53
    • 8
    Polyklonal
    Konjugat
    • 35
    • 5
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser PSCA Antikörper ist unkonjugiert
    Applikation
    • 46
    • 18
    • 13
    • 13
    • 10
    • 6
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
    Produktmerkmale
    Polyclonal Antibody
    Aufreinigung
    Antigen affinity purification
    Immunogen
    Synthetic peptide of human PSCA
    Isotyp
    IgG
    Top Product
    Discover our top product PSCA Primärantikörper
  • Applikationshinweise
    WB 1:500-1:2000, IHC 1:20-1:100, ELISA 1:5000-1:10000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.78 mg/mL
    Buffer
    PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C. Avoid freeze / thaw cycles.
  • Target
    PSCA (Prostate Stem Cell Antigen (PSCA))
    Andere Bezeichnung
    PSCA (PSCA Produkte)
    Synonyme
    PRO232 antikoerper, 2210408B04Rik antikoerper, PSCA antikoerper, prostate stem cell antigen antikoerper, PSCA antikoerper, Psca antikoerper, LOC482068 antikoerper
    Hintergrund
    PSCA (Prostate Stem Cell antigen) is a cell surface antigen, which is overexpressed in ~40 % of primary prostate cancers and in as many as 100 % of metastatic ones. PSCA is also overexpressed in a majority of transitional cell and pancreatic carcinomas. Antibody directed against PSCA inhibits tumorigenesis, slows tumor growth, prolongs survival and prevents metastasis in a preclinical zenograft model indicating that PSCA may have utility as a prognostic marker and/or therapeutic target in prostate cancer.
    Molekulargewicht

    Observed_MW: Refer to figures

    Calculated_MW: 13 kDa

    UniProt
    O43653
Sie sind hier:
Kundenservice